Managing emotional distress in glaucoma patients
Treating Psychosocial Distress in Glaucoma
This study is trying out a new mobile app treatment to help people with glaucoma who are feeling emotionally stressed to see if it can make a difference for them.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 45 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Duke University Academic / other |
| Locations | 1 site (Durham, North Carolina) |
| Trial ID | NCT06053307 on ClinicalTrials.gov |
What this trial studies
This study aims to develop and refine a behavioral intervention for patients with primary open-angle glaucoma who experience psychosocial distress. The approach involves three phases: first, creating a baseline intervention based on Acceptance and Commitment Therapy (ACT) delivered through a mobile app. Next, qualitative interviews with patients and health professionals will help refine this intervention. Finally, a pilot study will assess the acceptability and feasibility of the refined intervention among glaucoma patients.
Who should consider this trial
Good fit: Ideal candidates are adults aged 18 and older diagnosed with mild to severe chronic glaucoma and experiencing at least mild psychosocial distress.
Not a fit: Patients with borderline glaucoma, recent glaucoma surgery, major medical conditions, or significant psychiatric disorders may not benefit from this study.
Why it matters
Potential benefit: If successful, this intervention could significantly improve the emotional well-being of glaucoma patients dealing with distress.
How similar studies have performed: While this approach is innovative, similar interventions targeting psychosocial distress in chronic conditions have shown promise, suggesting potential for success.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria * diagnosed with mild, moderate, or severe chronic glaucoma (e.g., POAG), * had a visual field within the past year at the main Duke Eye Center, * been prescribed pressure lowering eye drop medication, * at least mild distress (based on PHQ-4), * 18 years old, * able to understand, speak, and read English, and * be able to provide informed consent. Exclusion Criteria * diagnosed with borderline glaucoma or as a glaucoma suspect, * had a glaucoma surgery in past month (e.g., trabeculectomy, glaucoma drainage device/tube), * visual acuity of worse than 20/70 in the better seeing eye, * diagnosed with a major medical conditions (e.g., cancer, or another visual disorder, like macular degeneration), * diagnosed with a psychiatric conditions (e.g., schizophrenia, bipolar disorder), and * reported or suspected cognitive impairment indicated by provider or chart review.
Where this trial is running
Durham, North Carolina
- Duke University Eye Center — Durham, North Carolina, United States (Recruiting)
Study contacts
- Study coordinator: Samuel Berchuck, PhD
- Email: sib2@duke.edu
- Phone: (919) 613-4975
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.